Moderna skyrockets 11% after receiving additional $472 million of funding, starting Phase 3 trial of COVID-19 vaccine

5:33am PDT - July 27th, 2020    moderna stock - Business Insider

• Moderna on Sunday announced it received a commitment of up to $472 million in additional funding from its contract with the Biomedical Advanced Research and Development Authority. 
• The company on Monday announced that the Phase 3 trial for i…